PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
27752061-6	2016	By inhibiting PTP1B activity, regorafenib treatment augmented the stability of PITX1 protein and upregulated the expression of p120RasGAP in CRC.	regorafenib	30-41	RAS p21 protein activator 1	Homo sapiens	127-137	
27752061-7	2016	Importantly, we found that this PTP1B-dependant PITX1/p120RasGAP axis determines the in vitro anti-CRC effects of regorafenib.	regorafenib	114-125	RAS p21 protein activator 1	Homo sapiens	54-64	
27752061-10	2016	Regorafenib inhibited CRC survival through reserving PTP1B-dependant PITX1/p120RasGAP downregulation.	regorafenib	0-11	RAS p21 protein activator 1	Homo sapiens	75-85